Adviye Ergul

Dr. Adviye Ergul earned her M.D. from The University of Istanbul Cerrahpasa Medical School in Istanbul, Turkey in 1987. After her residency in Clinical Biochemistry at Haseki Hospital in Istanbul, she earned her Ph.D. from the University of Miami School of Medicine, Department of Biochemistry and Molecular Biology, in 1995. She joined the Program in Clinical and Experimental Therapeutics at the University of Georgia College of Pharmacy as an Assistant Professor in 2000. In 2007, she joined the Department of Physiology at the Medical College of Georgia and became a full Professor in 2009 and a Regents Professor in 2017. She relocated her research program to the Department of Pathology & Laboratory Sciences at the Medical University of South Carolina in Oct 2018. The overall goal of Ergul Laboratory is to enable the development of innovative strategies and therapeutics for the prevention and treatment of diabetes and hypertension-associated complications including vascular cognitive impairment (VCID) and stroke. As a vascular physiologist, Dr. Ergul championed efforts to develop preventive and therapeutic strategies for vascular protection and restoration through a better understanding of the mechanisms regulating vascular function and structure. She has investigated the role of the endothelin system in cardio/cerebrovascular complications of diabetes extensively. She published over 200 peer-reviewed papers in top journals in her field including Diabetes and Stroke. She has been involved, as an editorial board member or reviewer, in several journals including Stroke, Diabetes, Circulation Research, and Hypertension. She has served in research organizations and funding agencies in the US and abroad. Her research has been continuously funded by NIH, VA Merit, AHA, and ADA since she started her own research program in 1997. She currently holds VA Senior Research Career Scientist Award, VA Merit Award, and two NIH RO1s as well as multiple fellowships for her trainees.